期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Gut microbiota in a population highly affected by obesity and type 2 diabetes and susceptibility to COVID-19
1
作者 Jaime García-Mena Karina Corona-Cervantes +9 位作者 Daniel Cuervo-Zanatta Tizziani Benitez-Guerrero JuanManuel Vélez-Ixta Norma Gabriela Zavala-Torres Loan Edel Villalobos-Flores Fernando Hernández-Quiroz Claudia Perez-Cruz Selvasankar Murugesan Fernando Guadalupe Bastida-González Paola Berenice Zárate-Segura 《World Journal of Gastroenterology》 SCIE CAS 2021年第41期7065-7079,共15页
Coronavirus disease 2019(COVID-19)is a disease produced by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)and it is currently causing a catastrophic pandemic affecting humans worldwide.This disease has bee... Coronavirus disease 2019(COVID-19)is a disease produced by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)and it is currently causing a catastrophic pandemic affecting humans worldwide.This disease has been lethal for approximately 3.12 million people around the world since January 2020.Globally,among the most affected countries,Mexico ranks third in deaths after the United States of America and Brazil.Although the high number of deceased people might also be explained by social aspects and lifestyle customs in Mexico,there is a relationship between this high proportion of deaths and comorbidities such as high blood pressure(HBP),type 2 diabetes,obesity,and metabolic syndrome.The official epidemiological figures reported by the Mexican government have indicated that 18.4%of the population suffers from HBP,close to 10.3%of adults suffer from type 2 diabetes,and approximately 36.1%of the population suffers from obesity.Disbalances in the gut microbiota(GM)have been associated with these diseases and with COVID-19 severity,presumably due to inflammatory dysfunction.Recent data about the association between GM dysbiosis and metabolic diseases could suggest that the high levels of susceptibility to SARSCoV-2 infection and COVID-19 morbidity in the Mexican population are primarily due to the prevalence of type 2 diabetes,obesity,and metabolic syndrome. 展开更多
关键词 SARS-CoV-2 COVID-19 High blood pressure HYPERTENSION Type 2 diabetes OBESITY Metabolic syndrome Gut microbiota IMMUNITY
下载PDF
Synthesis and Characterization of KFeP_(2)O_(7) Nanoparticles Implanted in Silica
2
作者 Eduardo Ordónez Regil Enrique Ordónez Regil +1 位作者 Nidia García González Samuel R.Barocio 《American Journal of Analytical Chemistry》 2012年第8期512-517,共6页
Rivers and aquifers are increasingly affected worldwide by the action of agro-industrial pollution. Facing this challenge, nanoparticles have found a wide range of applications in the decontamination and remediation o... Rivers and aquifers are increasingly affected worldwide by the action of agro-industrial pollution. Facing this challenge, nanoparticles have found a wide range of applications in the decontamination and remediation of water, given the characteristics which make them highly reactive to specific substances. One of the simplest ways of gaining access to these particles is through their synthesis over a sufficiently rigid matrix of manageable size. This report describes the synthesis and characterization of nanoparticles of iron and potassium diphosphate (KFeP2O7) synthesized on silica gel beads (SiO2). Analysis by X-ray diffraction (XRD), scanning electron microscopy (SEM) and X-ray photoelectron spectroscopy (XPS) have been applied in order to determine the mineral phases and morphology of the synthesized compounds. Complementary tests were conducted so as to determine surface characteristics such as specific area by the BET method and point of zero charge (pHpzc) by mass titration. The acid-base titration enabled to determine the adsorptive nature of nanoparticles and their response to a pH range from 1 to 12. 展开更多
关键词 KFeP_(2)O_(7) Synthesis NANOPARTICLES XRD and XPS Analysis KFeP_(2)O_(7) Nanoparticles Implanted in Silica
下载PDF
墨西哥随机盲法复检抗酸杆菌涂片新的外部质量评价指南实验项目结果报告
3
作者 A. Martinez S. Balandrano +6 位作者 A. Parissi A. Zuniga M. Sanchez J. Ridderhof H. B. Lipman B. Madison 张宗德 《结核与肺部疾病杂志》 2005年第4期158-161,共4页
地点:实施国家结核病控制规划中的抗酸菌镜检外部质量保证的墨西哥实验室。包括对本地实验室报告的 100%抗酸菌阳性涂片和 10%阴性涂片的复检。在墨西哥使用非随机和非盲法重检时很少发现错误。目的:对墨西哥两个州的当地结核病实验室... 地点:实施国家结核病控制规划中的抗酸菌镜检外部质量保证的墨西哥实验室。包括对本地实验室报告的 100%抗酸菌阳性涂片和 10%阴性涂片的复检。在墨西哥使用非随机和非盲法重检时很少发现错误。目的:对墨西哥两个州的当地结核病实验室一年的实验项目抗酸菌痰涂片随机盲法重检结果进行评价,决定这种方法在以后实施的可行性。设计:为减少误差,来自流行病学诊断与参比研究所国家结核病实验室(InDRE)的工作人员对每个州的当地实验室抗酸菌涂片进行每季度一次的统计学抽样及现场评价。抗酸菌涂片复检在本州的实验室进行,如遇结果不符时上交 InDRE 解决。结果:对抗酸菌涂片进行随机盲法复检比非随机、非盲法重检时发现错误的概率大得多。结论:随机盲法重检可以更加准确地估计抗酸菌涂片镜检的结果,提高诊断及对治疗效果的监测。 展开更多
关键词 质量保证 实验室检查 AFB镜检 结核病 随机盲法 阳性涂片 实验项目 墨西哥 复检 结果报告
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部